Dynamk Capital β Full Portfolio
14 tracked investments Β· listed companies and verified rows first
Xcelthera develops cell therapy platform technology, serving the biotech and therapeutic development sector.
BiotechDeep TechHardwareHealthtechMedical Devices
Brian Feth(Chief Executive Officer)James Lim(Chief Scientific Officer)Shannon Eaker(Chief Technology Officer)
Co-investorsAvego BioScience Capital
CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams.
BiotechDeep TechHardwareMedical DevicesAtlanta, US
Alla Zamarayeva, PhD(CEO & Co-founder)Todd Sulchek, PhD(CSO & Co-founder)Alex Alexeev, PhD(Co-founder)Alla Zamarayeva(CEO & Co-founder)Todd Sulchek(CSO & Co-founder)Alex Alexeev(Co-founder)
Co-investorsCota CapitalGreatPoint VenturesM VenturesEmbark VenturesKhosla Ventures
Develops analytical testing devices that minimize sample volume requirements for particle count determination in biopharmaceutical analysis.
bit.bio is a synthetic biology company that engineers human induced pluripotent stem cells into defined cell types for research, drug discovery, and cell therapy applications.
BiotechDeep TechHealthtechMedical Devices
Dr Mark Kotter(Founder)Przemek Obloj(CEO)Emma Pepperellin
Co-investorsForesite CapitalBlueYard CapitalARCH Venture PartnersGood AI CapitalHAWKTAILMetaplanet+2 more
Curi Bio provides a preclinical drug development platform combining 3D human tissue models of disease (cardiac and skeletal muscle), biosystems for functional analysis, and AI/ML-based insights to assess drug safety, efficacy, and potency.
AI & Machine LearningBiotechMedical Devices
Elliot Fisher(Cofounder)in
Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.
AI & Machine LearningBiotechMedical DevicesNew York, US
Maria Pineda, PhD(CEO & Co-founder)Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Executive Officer, Director, Promoter)Maria Luisa Pineda(Executive Officer, Director, Promoter)Maria Luisa Pineda, PhD.(Founder)in
Co-investorsHAWKTAILM12 (Microsoft's Venture Fund)Madrona Venture GroupRed Cell IncubationDolby Family VenturesThird Kind Venture Capital
Lucid Scientific develops Resipher, a technology for live, continuous, and noninvasive monitoring of cellular oxygen consumption rate to study cell metabolism.
BiotechDeep TechHardwareAtlanta, US
Samuel Walker Inman(Executive Officer, Director)Ian W. Hunter(Executive Officer, Director)
BoardDr. Gustavo Mahler(Director)in
Co-investorsGRA Venture
Manufactures handheld cell culture monitors that measure oxygen consumption in multi-well plates for continuous real-time cell analysis.
A stem cell tools and technology company providing standardized platforms to accelerate regenerative medicine development and clinical trials.
BiotechFrederick, US
Jon Rowley(Director)Timothy Kelly(Executive Officer, Director)Margot Connor(Executive Officer, Director)Uplaksh Kumar(Chief Operating Officer)
BoardMartin Westberg(Director)Rob Carlson(Director)
Co-investorsMaryland TEDCOTEDCOVanedge CapitalVanedge Capital Limited PartnershipAvant Bio
Vernal Biosciences is a contract development and manufacturing organization (CDMO) offering mRNA and LNP-mRNA process development, GMP manufacturing, custom synthesis, and analytical testing.
Advanced ManufacturingBiotechColchester, US
Christian Cobaugh(Executive Officer, Director)
BoardErrik Anderson(Director)
Designs hardware and AI-driven software platforms for drug screening, primary cell analysis, and cell therapy manufacturing to enhance safety and performance.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.